Financial News

• Double-digit growth in number of patients treated to nearly 2.5 million • Consolidated revenue rises to EUR 3,537.3 million, consolidated net income (EAT) totals EUR 172.3 million • Regulatory challenges impacting cash flow • Asklepios hospitals a reliable pillar of support during coronavirus crisis

• NOT INTENDED FOR DISTRIBUTION, PUBLICATION OR DISSEMINATION (AS A WHOLE OR IN PART) IN OR FROM ANY JURISDICTION WHERE IT WOULD CONSTITUTE A VIOLATION OF ANY APPLICABLE LAW WITHIN SUCH JURISDICTION • Acceptance period runs from April 8 to May 6, 2020 • Offer price of €18.00 per share • No minimum acceptance threshold

• NOT INTENDED FOR DISTRIBUTION, PUBLICATION OR DISSEMINATION (IN WHOLE OR IN PART) IN OR FROM ANY JURISDICTION WHERE IT WOULD CONSTITUTE A VIOLATION OF ANY APPLICABLE LAW WITHIN SUCH JURISDICTION

• Company founder Eugen Münch and Asklepios pool their combined shareholding totaling almost 50% of RHÖN-KLINIKUM AG in a joint venture • Announcement of takeover offer by Asklepios to all remaining shareholders of RHÖN-KLINIKUM AG with a cash offer price of € 18.00 per RHÖN-share • Following completion of the transaction, the two partners aim to acquire the majority of voting rights in RHÖN-KLINIKUM AG • Eugen Münch, founder and Chairman of the Supervisory Board of RHÖN-KLINIKUM AG: “We are joining forces with the shared goal of realizing our vision for healthcare in Germany under the umbrella of an Asklepios/ RHÖN group” • Dr. Bernard große Broermann, founder and sole shareholder of Asklepios: “Today’s agreement marks a milestone for the future of healthcare in Germany”